| Journal | Issue | Title | Abstract | File |
| REMEDIUM | No 3 (2023) | Review and comparison of existing practices for the implementation of municipal programs of prospective public health | Abstract |
![]() (Rus) |
| Lang A.A., Mylnikova D.G. | ||||
| REMEDIUM | No 13S (2018) | Review of cosmetics sales in pharmacies: 2017 results | Abstract |
![]() (Rus) |
| Nechaeva J. | ||||
| REMEDIUM | No 3 (2019) | Review of Federal medicine assistance schemes | Abstract |
![]() (Rus) |
| Kovaleva K.A., Narkevich I.A., Nemyatykh .D., Vasyagina Y.A. | ||||
| REMEDIUM | No 9 (2020) | Review of pharmacy sales of plasters and self-adhesive dressings | Abstract |
![]() (Rus) |
| Nechaeva Y. | ||||
| REMEDIUM | No 3 (2019) | Review of PIC/S guidance on classification of GMP deficiencies | Abstract |
![]() (Rus) |
| Orlov V.A. | ||||
| REMEDIUM | No 10 (2019) | Review of the Russian pharmaceutical market: results of the 1st half of 2019 | Abstract |
![]() (Rus) |
| Kalinina N. | ||||
| REMEDIUM | No 1 (2021) | Reyting aptechnykh setey Rossii po itogam 2020 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 2 (2021) | Reyting aptechnykh setey Rossii po itogam I kvartala 2021 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 3 (2021) | Reyting aptechnykh setey Rossii po itogam I–II kv. 2021 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 7-8 (2020) | Reyting aptechnykh setey Rossiipo itogam 1-go polugodiya 2020 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 7-8 (2020) | Rezervy polnogo tsikla | Abstract |
![]() (Rus) |
| Kuminova E. | ||||
| REMEDIUM | No 2 (2025) | Risk analysis for the quality of medicines of pharmaceutical manufacturing using a burette unit | Abstract |
![]() (Rus) |
| Voronina E.A., Vorobyeva N.V., Egorova S.N. | ||||
| REMEDIUM | No 4 (2018) | Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia | Abstract |
![]() (Rus) |
| Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A. | ||||
| REMEDIUM | No 1 (2023) | Risk-oriented approach in the design information’s stand of pharmacies | Abstract |
![]() (Rus) |
| Gulbekova O.V., Ivanova O.V., Robertus A.I., Kolosov Y.A., Kurkin D.V., Krasheninnikov A.E., Kudrin R.A. | ||||
| REMEDIUM | No 2 (2022) | Risks in the lifestyle of students | Abstract |
![]() (Rus) |
| Gureev S.A., Mingazov R.N., Sadykova R.N., Shegurova K.A. | ||||
| REMEDIUM | No 11 (2018) | Road map and BAA market: forecasts and risks | Abstract |
![]() (Rus) |
| Borzova M. | ||||
| REMEDIUM | No 5 (2019) | Rossiya stanet odnoy iz pervykh stran, pristupivshikh k primeneniyu innovatsionnoy vaktsiny protiv gepatita B | Abstract |
![]() (Rus) |
| Article E. | ||||
| REMEDIUM | No 1-2 (2019) | Rossiyskaya kompaniya nauchila neyroset' iskat' metastazy | Abstract |
![]() (Rus) |
| Article E. | ||||
| REMEDIUM | No 4 (2019) | Rossiyskie vaktsiny otsenili mezhdunarodnye eksperty | Abstract |
![]() (Rus) |
| ShIROKOVA I. | ||||
| REMEDIUM | No 11-12 (2020) | Rossiyskiy farmatsevticheskiy forum o rasshirenii perechnya ZhNVLP | Abstract |
![]() (Rus) |
| Kuminova E. | ||||
| REMEDIUM | No 10 (2019) | Rossiyskiy rynok implantov dlya osteosinteza | Abstract |
![]() (Rus) |
| Vanin A. | ||||
| REMEDIUM | No 10 (2019) | Rossiyskiy rynok rastet blagodarya gossegmentu | Abstract |
![]() (Rus) |
| Shirokova I. | ||||
| REMEDIUM | No 1-2 (2018) | Russia builds the future without tobacco | Abstract |
![]() (Rus) |
| Prozherina J., Shirokova I. | ||||
| REMEDIUM | No 12 (2019) | Russia: export of FPPs at аugust-end 2019 | Abstract |
![]() (Rus) |
| - -. | ||||
| REMEDIUM | No 12 (2019) | Russia: import of FPPs at аugust-end 2019 | Abstract |
![]() (Rus) |
| - -. | ||||
| 601 - 625 of 832 Items | << < 20 21 22 23 24 25 26 27 28 29 > >> | |||
